| [February 09, 2016] |
 |
Global Melanoma Pipeline Review 2015 - Research and Markets
Research and Markets (http://www.researchandmarkets.com/research/hq2d75/melanoma)
has announced the addition of the "Melanoma
- Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic
development for Multiple Myeloma (Kahler Disease), complete with
comparative analysis at various stages, therapeutics assessment by drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type, along with latest updates, and featured news and press
releases. It also reviews key players involved in the therapeutic
development for Melanoma and special features on late-stage and
discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
-
Introduction
-
Melanoma Overview
-
Therapeutics Devlopment
-
Pipeline Products for Melanoma - Overview
-
Pipeline Products for Melanoma - Comparative Analysis
-
Melanoma - Therapeutics under Development by Companies
-
Melanoma - Therapeutics under Investigation by Universities/Institutes
-
Melanoma - Pipeline Products Glance
-
Late Stage Products
-
Clinical Stage Products
-
Early Stage Products
-
Melanoma - Products under Development by Companies
-
Melanoma - Products under Investigation by Universities/Institutes
-
Melanoma - Companies Involved in Therapeutics Development
Companies Mentioned - Sample List
-
AB Science SA
-
AbbVie Inc.
-
ACF Pharmaceuticals, LLC
-
Adamis Pharmaceuticals Corporation
-
Adaptimmune Limited
-
Aduro BioTech, Inc.
-
Advaxis, Inc.
-
Aeterna Zentaris Inc.
-
Affichem SA
-
Agalimmune Ltd
-
Agenus, Inc.
-
Agilvax, Inc.
-
AGV Discovery, SAS (News - Alert)
-
AIMM Therapeutics B.V.
-
Alethia Biotherapeutics Inc.
-
Altor BioScience Corporation
-
Amgen Inc.
-
Anavex Life Sciences Corp.
-
Antigen Express, Inc.
-
APEIRON Biologics AG
-
Aphios Corporation
-
APO-T B.V.
-
Aposense Ltd.
-
Applied Immune Technologies Ltd
-
Aptose Biosciences Inc.
-
Arisaph Pharmaceuticals, Inc.
-
Array BioPharma Inc.
-
Arrowhead Research Corporation
-
Astex Pharmaceuticals, Inc.
-
AstraZeneca Plc
-
Aurigene Discovery Technologies Limited
-
Axelar AB
-
Azaya Therapeutics, Inc.
-
Basilea Pharmaceutica AG
For more information visit http://www.researchandmarkets.com/research/hq2d75/melanoma
View source version on businesswire.com: http://www.businesswire.com/news/home/20160209006500/en/
[ Back To TMCnet.com's Homepage ]
|
